Pas de connexion internet — affichage de la version enregistrée de la page.

Ascentage Pharma…

USUSD
← Vers le Screener

Ascentage Pharma Group International (US:AAPG) — Biotechnology: Pharmaceutical Preparations. Nombre de places boursières sur lesquelles les actions de la société sont cotées : 1. Sur cette page : cours et graphique, dividendes, principaux actionnaires et historique du nombre d'actions.

À propos de l'entreprise

Site Web
ascentage.cn
Relations avec les Investisseurs
ascentage.cn/investor-relations/
Secteur
Health Care · Biotechnology: Pharmaceutical Preparations
Siège Social
SUZHOU , JIANGSU, China
Direction
Dajun Yang
Employés
828
IPO
2019-10-28
Actions en Circulation
373.32 M au 2026-04-01
Flottant
71.53 M
Capitalisation Boursière
10.71 Md CNY
Initiés
0%
Investisseurs Institutionnels
0.04%
Secteur d'Activité (SIC)
Pharmaceutical Preparations
Description

Ascentage Pharma Group International, a clinical-stage biotechnology company, develops therapies for cancers, chronic hepatitis B virus (HBV), and age-related diseases in Mainland China. The company's primary product candidate is HQP1351, a BCR-ABL inhibitor targeting BCR-ABL1 mutants, including those with the T315I mutation. It also develops APG-2575, an oral administered Bcl-2 selective inhibitor for hematologic malignancies and solid tumors; APG-115, an oral small molecule inhibitor of the MDM2-p53 protein-protein interactions to treat solid tumors and hematological malignancies; and APG-1252, a small molecule drug to restore apoptosis through dual inhibition of the Bcl-2 and Bcl-xL proteins for the treatment of small-cell lung cancer, non-small cell lung cancer, neuroendocrine tumor, and non-Hodgkin's lymphoma. In addition, the company is developing APG-1387, a small-molecule inhibitor of apoptosis proteins for advanced solid tumors and chronic HBV infection; APG-5918, an orally available and selective embryonic ectoderm development inhibitor. In addition, it is involved in medical research and development; clinical development; clinical trials operations; venture capital investment; rental of buildings; and provision of science and technology promotion services. The company has strategic partnership with biotechnology and pharmaceutical companies; research institutions; and Peking University to build a collaborative system for hematological oncology. Ascentage Pharma Group International was founded in 2009 and is headquartered in Suzhou, China.

publicité

Bourses et Tickers

BourseTickerDevisePrixType
US USA StocksAAPGUSD14.88 -0.70%actions ordinaires

Prix

US:AAPG · USD
jour de hausse jour de baisseSurvolez / touchez un jour — cours d'ouverture, de clôture, plus haut et plus bas

Principaux Actionnaires

DétenteurParticipationActionsDate du Rapport
Point72 Asset Management…0.01%13 8412026-06-30
Fidelity Concord Street…0%1 5582026-08-31
Morgan Stanley0%9192026-06-30
Wells Fargo & Company0%2002026-06-30
Eversource Wealth Adviso…0%242026-06-30
UBS Group AG0%152026-06-30
Blackrock Inc.0%62026-06-30
Royal Bank of Canada0%62026-06-30
Nisa Investment Advisors…0%52026-09-30
Caitong International As…0%12026-06-30